Abstract
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Current Diabetes Reviews
Title:Type 2 Diabetes and its Impact on the Immune System
Volume: 16 Issue: 5
Author(s): Afiat Berbudi*, Nofri Rahmadika , Adi Imam Tjahjadi and Rovina Ruslami
Affiliation:
- Infectious Disease Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung,Indonesia
Keywords: Type 2 diabetes, hyperglycemia, immune dysfunction, comorbidity, infection, treatment outcome.
Abstract:
Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia.
Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.
Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.
Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.
Export Options
About this article
Cite this article as:
Berbudi Afiat *, Rahmadika Nofri , Tjahjadi Imam Adi and Ruslami Rovina , Type 2 Diabetes and its Impact on the Immune System, Current Diabetes Reviews 2020; 16 (5) . https://dx.doi.org/10.2174/1573399815666191024085838
DOI https://dx.doi.org/10.2174/1573399815666191024085838 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Current Cancer Drug Targets Fragile X Syndrome: Psychiatric Manifestations, Assessment and Emerging Therapies
Current Psychiatry Reviews Role of Protein Tyrosine Phosphatases in Plants
Current Genomics Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Toxicogenomics of Cationic Lipid-based Vectors for Gene Therapy: Impact of Microarray Technology
Current Drug Delivery Lipid Raft in Cardiac Health and Disease
Current Cardiology Reviews The Antioxidants and Pro-Antioxidants Network: An Overview
Current Pharmaceutical Design The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes
Current Diabetes Reviews Retroviral Protein Transfer: Falling Apart to Make an Impact
Current Gene Therapy Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Editorial [Hot Topic: Relationship Between Epithelial Barrier and Microorganisms (Guest Editor: Nadia Berkova)]
Current Immunology Reviews (Discontinued) B Cells and Beyond: Therapeutic Opportunities Targeting Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Current Protein & Peptide Science HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders The Potential Role of Statins in Pneumonia
Current Respiratory Medicine Reviews Nanotools for the Delivery of Antimicrobial Peptides
Current Drug Targets Genetic Variations of the Hemostatic System as Risk Factors for Venous and Arterial Thrombotic Disease
Current Genomics The Use of Biologics for Psoriasis in Asia-Pacific Region
Current Rheumatology Reviews Expression and Function of Bcl-2 Proteins in Melanoma
Current Genomics subject Index To Volume 2
Current Molecular Medicine